About Evaro
Evaro is a company based in Norwich (United Kingdom) founded in 2017 by Thuria Wenbar. Evaro has raised $26.5 million across 2 funding rounds from investors including Syndicate Room, University of East Anglia and Cornerstone VC. The company has 27 employees as of March 31, 2022. Evaro operates in a competitive market with competitors including Surescripts, Photon, WonDRx, Foundation Health and Tandem, among others.
- Headquarter Norwich, United Kingdom
- Employees 27 as on 31 Mar, 2022
- Founders Thuria Wenbar
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Total Access Health Limited
- Date of Incorporation 21 Mar, 2017
- Jurisdiction NORWICH, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$26.5 M (USD)
in 2 rounds
-
Latest Funding Round
$25 M (USD), Series A
Jan 27, 2026
-
Investors
Syndicate Room
& 7 more
-
Employee Count
27
as on Mar 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Evaro
Unlock access to complete
Unlock access to complete
Funding Insights of Evaro
Evaro has successfully raised a total of $26.5M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $25 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Evaro
Evaro has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Syndicate Room, University of East Anglia and Cornerstone VC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are made in early-stage tech startups.
|
Locked | Locked | Locked | |
|
Early-stage investments are provided by this London-based VC firm.
|
Locked | Locked | Locked | |
|
Israeli multi-fund firm focused on technology investments since 1999.
|
Locked | Locked | Locked |
Investor details for Evaro
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Evaro
Investment portfolio details for Evaro
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Evaro
Detailed financials for Evaro
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Evaro Comparisons
Peer comparison for Evaro
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Evaro
Evaro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Surescripts, Photon, WonDRx, Foundation Health and Tandem, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Health information exchange and e-prescribing are facilitated for care coordination.
|
|
| Locked | Locked | Locked |
Sheet metal processing services are provided to industrial clients.
|
|
| Locked | Locked | Locked |
EHR facilitator solutions are provided for healthcare professionals' record management.
|
|
| Locked | Locked | Locked |
Provider of virtual health and telehealth platform for pharmacies and hospitals
|
|
| Locked | Locked | Locked |
Hybrid teams are matched with co-tenants through an office-share platform.
|
Detailed competitors of Evaro
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Evaro
Complete news archive for Evaro
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Evaro
Evaro was founded in 2017 and raised its 1st funding round 7 years after it was founded.
Evaro is headquartered in Norwich, United Kingdom. It is registered at Norwich, Norfolk, United Kingdom.
Thuria Wenbar is the current CEO of Evaro. They have also founded this company.
Evaro is a funded company, having raised a total of $26.5M across 2 funding rounds to date.
As of Mar 31, 2022, the latest employee count at Evaro is 27.
Evaro was founded in 2017 in Norwich, United Kingdom, as an AI-driven platform in the health technology sector. Prescription medication services are integrated for brands, with regulation and warehouse pharmacy fulfillment managed. Clinical consultations and drug prescriptions are facilitated through seamless digital operations, supporting healthcare accessibility across the region. Leadership is provided by Co-Founder and CEO Thuria Wenbar.
Evaro's top competitors include Surescripts, Tandem and G-MEDS.
Evaro has 8 investors. Key investors include Syndicate Room, University of East Anglia, Cornerstone VC, Exceptional Ventures, and Catalyst Investments.